NCT01662648View on ClinicalTrials.gov

Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

1,117

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2009

Conditions

Schizophrenia

Interventions

DRUG

Paliperidone ER

Paliperidone extended-release (ER) tablet in dose range of 3 to 12 milligram (mg) per day will be given orally for 6 months as per Investigator's discretion.